Search

Your search keyword '"Sertoli MR"' showing total 8 results
Start Over Author "Sertoli MR" Language italian
8 results on '"Sertoli MR"'

2. [Merkel's tumor. Some comments and the authors' personal cases].

Author

Gipponi M, Queirolo P, Di Somma C, Canavese G, Moresco L, Sertoli MR, and Cafiero F

Subjects
Aged, Aged, 80 and over, Carcinoma, Merkel Cell therapy, Female, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local therapy, Skin pathology, Skin Neoplasms therapy, Carcinoma, Merkel Cell pathology, Skin Neoplasms pathology
Abstract

The clinical features of 7 cases of primary neuroendocrine carcinoma of the skin (Merkel cell tumor) are reported. This cancer arises in the dermis and subcutaneous tissues of elderly individuals. Natural history is characterized by local recurrences (30%), regional lymph node metastases (65%) and distant metastases (40%). Surgery is the elective treatment, chemotherapy and radiotherapy resulted in only short-term palliative response.

Published
1992

3. [Chemotherapeutic treatment of advanced ovarian carcinoma. Preliminary results of the Piedmont-Liguria Cooperative Group].

Author

Conte PF, Rosso R, Bruzzone M, Sertoli MR, Rubagotti A, Santi L, Carnino F, Cottini M, Mossetti C, and Gatti M

Subjects
Cisplatin administration & dosage, Cisplatin therapeutic use, Cyclophosphamide administration & dosage, Cyclophosphamide therapeutic use, Doxorubicin therapeutic use, Drug Evaluation, Female, Humans, Ovarian Neoplasms pathology, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Ovarian Neoplasms drug therapy
Published
1984

4. [Antibiotic preparation in operations on the large intestine. Experimental study].

Author

Cafiero F, Sertoli MR, Rubagotti A, Adami GF, and Rollandi GA

Subjects
Adult, Aged, Anti-Bacterial Agents administration & dosage, Bacterial Infections prevention & control, Drug Therapy, Combination, Female, Humans, Injections, Intravenous, Male, Middle Aged, Postoperative Complications, Preoperative Care, Colonic Neoplasms surgery, Erythromycin administration & dosage, Intestinal Fistula surgery, Lincomycin administration & dosage, Neomycin administration & dosage, Rectal Neoplasms surgery
Abstract

A controlled study was mounted to assess the possible benefit of a single phlebo administration of 600 mg lincomycin 1 hr prior to colon surgery, in addition to the erythromycin + neomycin combination proposed by Nichols, as a means of constituting a further pharmacological barrier to the spread of anaerobic bacteria. The study currently comprises two groups of 15 patients fully comparable with regard to pathology distribution and randomly assigned to the E.N. and the E.N.L. protocol respectively. Six instances of septic complication have been observed, five in the group prepared with E.N. and 1 prepared with E.N.L. No significance can be attached to the different incidence of complications in the two arms of the study, owing to the small number of cases examined.

Published
1981

5. [Second instance chemotherapy with high-dose cisplatin in patients with advanced ovarian neoplasms in progression or recurrence after treatment with cisplatin].

Author

Bruzzone M, Conte PF, Chiara S, Sertoli MR, Rosso R, Ragni N, Foglia G, Conio A, and Pescetto G

Subjects
Adult, Drug Administration Schedule, Drug Evaluation, Female, Humans, Middle Aged, Ovarian Neoplasms pathology, Cisplatin administration & dosage, Neoplasm Recurrence, Local drug therapy, Ovarian Neoplasms drug therapy
Published
1985

6. [Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients].

Author

Bernengo MG, Doveil GC, Appino A, Sertoli MR, Ardizzoni A, and Vidili MG

Subjects
Drug Evaluation, Female, Humans, Injections, Subcutaneous, Interferon alpha-2, Interferon-alpha administration & dosage, Interferon-alpha adverse effects, Male, Recombinant Proteins, Remission Induction, Interferon Type I therapeutic use, Interferon-alpha therapeutic use, Melanoma therapy, Skin Neoplasms therapy
Published
1988

8. [Phase II study of 4-demethoxydaunorubicin in metastatic breast neoplasms].

Author

Lionetto R, Ardizzoni A, Repetto L, Pronzato P, Sertoli MR, and Rosso R

Subjects
Daunorubicin therapeutic use, Drug Evaluation, Humans, Idarubicin, Neoplasm Metastasis, Antibiotics, Antineoplastic therapeutic use, Breast Neoplasms drug therapy, Daunorubicin analogs & derivatives
Published
1985

Catalog

Books, media, physical & digital resources
See catalog results